Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.

PLoS One · 2018 · PMC6303064 · PMID 30576361

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significancep = 0.14not close (p > 0.1)

Although there was a trend seen in deterioration of T1 relaxation values in the gray matter and white matter lesions, the comparisons did not reach statistical significance (p = 0.14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.